Shift has created the first drug pipeline for cellular age reversal in humans. After compressing centuries of experiments into months with a virtual cell, Shift just validated safe age reversal across (real) human cell types. Shift are now proving this technology in mice and plan to monetise with Pharma for a subset of age-driven diseases. Research team from University of Cambridge and drug development team is ex-Alnylam, Moderna and GSK.
Company Details
- Employees
- 24
- Founded
- -
- Address
- Moneta (Building 280) Babraham Research Campus, Cambridge,cambridgeshire Cb22 3at,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://shiftbioscience.com
- HQ
- Cambridge, Cambridgeshire
Shift Bioscience Questions
Shift Bioscience's website is https://shiftbioscience.com
Shift Bioscience's LinkedIn profile is https://uk.linkedin.com/company/shiftbioscience
Shift Bioscience has
24 employees.
View email and phone details for 24
employees at Shift Bioscience.
Shift Bioscience's industry is
Biotechnology Research
Shift Bioscience's top competitors are
The Jackfruit Company,
Antiverse,
Kailera Therapeutics,
Clock.bio,
Tolerance Bio,
Liberation Bioindustries,
Arda Therapeutics,
Invios Innovative Immuno-Oncology,
Ikarovec,
Booster Therapeutics.
Shift Bioscience's categories are Biotechnology Research
Shift Bioscience's founding year is 2017
